Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8442176 | European Journal of Cancer | 2015 | 21 Pages |
Abstract
Most CRs remain uniquely able to report on progress against cancer by studies of variation in incidence (in time and place), detection and survival, referral and treatment patterns and their (side) effects in unselected patients, the latter especially in the (very) elderly. Programming and profiling its multiple and diverse clinical and prevention research is likely to promote involvement of public health and clinical stakeholders with a population-based research interest, increasingly patient groups and licensed 'buyers' of oncologic services.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jan Willem Coebergh, Corina van den Hurk, Stefano Rosso, Harry Comber, Hans Storm, Roberto Zanetti, Lidia Sacchetto, Maryska Janssen-Heijnen, Melissa Thong, Sabine Siesling, Janny van den Eijnden-van Raaij,